PCSK6 and clinical outcomes in the Pulmonary Fibrosis Foundation Patient Registry
Abstract Background Higher plasma proprotein convertase subtilisin/kexin type 6 (PCSK6) concentration has been associated with increased all-cause mortality in idiopathic pulmonary fibrosis (IPF). Its role across the broader spectrum of fibrotic interstitial lung disease (ILDs) remains unclear. We e...
Guardat en:
| Autors principals: | , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2026-04-01
|
| Col·lecció: | Respiratory Research |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1186/s12931-026-03642-1 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|